| CBOE Exchange | Netherlands Country |
Xtrackers SLI UCITS ETF 1D is an exchange-traded fund that aims to track the SLI Swiss Leader Index, which includes the 30 largest and most liquid blue-chip companies listed on the SIX Swiss Exchange. This ETF was launched on January 25, 2008, and is domiciled in Luxembourg. It is managed by Deutsche Asset & Wealth Management Investment S.A., with co-management provided by Deutsche Asset Management entities. The fund employs a representative sampling methodology to effectively replicate the index's performance, focusing on investments in large-cap stocks across diversified sectors within the Swiss public equity market. Notable holdings include major firms such as UBS Group AG, Roche Holding AG, Novartis AG, and Nestlé S.A., which collectively represent a significant portion of the ETF’s assets. With approximately 298 million in assets under management and an expense ratio of 0.25%, this ETF is designed to offer investors targeted exposure to Switzerland's leading firms, weighted by free-float adjusted market capitalization. The fund also distributes dividends semi-annually, yielding about 1.31%, thus presenting a viable investment opportunity reflecting Switzerland's strengths in pharmaceuticals, finance, consumer goods, and industrials.
This primary product is an exchange-traded fund designed to track the SLI Swiss Leader Index, offering investors access to a diverse range of major Swiss blue-chip companies.
The ETF provides semi-annual dividend distributions, yielding approximately 1.31%, contributing to the overall return on investment for shareholders.
With an expense ratio of 0.25%, the ETF ensures a cost-effective investment option, allowing more of the investor’s capital to work for them, rather than being consumed by fees.
The fund benefits from the robust management capabilities of Deutsche Asset & Wealth Management Investment S.A. and affiliated Deutsche Asset Management entities, providing seasoned oversight and strategic direction.
By investing in a representative sample of stocks across multiple sectors, including pharmaceuticals, finance, consumer goods, and industrials, the ETF offers well-rounded exposure to the Swiss market.